Skip to main content
Pharmsville Co., Ltd. logo

Pharmsville Co., Ltd. — Investor Relations & Filings

Ticker · 318010 ISIN · KR7318010006 KO Manufacturing
Open in API
Filings indexed 129 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 318010

About Pharmsville Co., Ltd.

http://pharmsville.net/

Pharmsville Co., Ltd. is a bio-healthcare company that develops, produces, and sells health functional foods and natural supplements. Founded in 2000, the company focuses on extending human healthspan through the research and development of novel ingredients, with a specialization in microbiome-based probiotics. Its product portfolio is marketed to both domestic and international consumers under brands such as 'Appletree Dr.'. The company supports its innovation through dedicated research facilities, including the Pharmsville Bio Lab, aiming to create health products that are as natural as possible for the human body.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled '분기보고서' (Quarterly Report) for the period January 1, 2026 to March 31, 2026 (27th fiscal term). It contains detailed sections on company overview, business description, share capital changes, share structure, and comprehensive business content, indicating substantive financial and corporate disclosures. It is clearly the interim financial report itself, not merely an announcement. This matches the definition for ’Interim / Quarterly Report’ (Code: IR). Q1 2026
2026-05-14 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a brief announcement about a change in the company's department affiliation from '중견기업부' (Mid-sized Enterprise Division) to '벤처기업부' (Venture Enterprise Division) with a specified effective date. It does not contain financial data, audit information, or detailed management or board changes. It is a regulatory announcement about an internal classification change. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-04-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the formal notice of results from a regular shareholders’ meeting held on March 26, 2026. It details the approval of financial statements, dividend resolutions, board composition, and shows vote tallies and percentages for each agenda item. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” for shareholder votes at a general meeting.
2026-03-26 Korean
기업가치제고계획(자율공시)
Regulatory Filings Classification · 85% confidence The document is a Korean voluntary disclosure (“자율공시”) titled “기업가치 제고 계획” (corporate value enhancement plan) outlining future operating targets, sustainable dividend policy, debt‐free management, and other forward‐looking items. It is not a full annual or quarterly financial report, an earnings release, a management change announcement, or a financing/capital‐raising notice. Rather, it is a miscellaneous regulatory filing with no specific category among the defined types. Therefore it is best classified under the fallback “Regulatory Filings” (RNS).
2026-03-26 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the 26th fiscal year (2025), covering company overview, history, capital structure, and detailed business operations. It is a formal, long-form regulatory filing submitted to the Financial Supervisory Service and Korea Exchange. It contains substantive financial and operational data, fitting the definition of an Annual Report (10-K) in the context of Korean corporate filings. FY 2025
2026-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 99% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company '팜스빌'. It provides a summary of the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, equity, revenue, profit/loss) for the current and previous fiscal years, and details regarding the external auditor. While it contains financial data, it is a standard regulatory disclosure announcement in Korea (DART system) notifying the market that the audit report has been submitted. It does not constitute the full, multi-page audited financial statements themselves, but rather the summary disclosure of the audit results. FY 2025
2026-03-18 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.